Jul 10, 2023 7:00am EDT Societal CDMO Selected by Spinnaker Biosciences to Provide CDMO Services to Support Clinical Development of Novel Therapeutic Candidate
Jun 29, 2023 7:00am EDT Societal CDMO Signs Master Service Agreement With CivicaScript to Provide CDMO Services
May 23, 2023 7:00am EDT Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator
May 09, 2023 4:05pm EDT Societal CDMO to Participate in RBC Capital Markets Global Healthcare Conference
May 08, 2023 7:00am EDT Societal CDMO Selected by Xequel Bio to Provide CDMO Services to Support Ongoing Clinical Development of iNexin™
May 03, 2023 4:05pm EDT Societal CDMO to Report Financial Results for First Quarter 2023 on May 10, 2023
Apr 12, 2023 7:00am EDT Societal CDMO Signs Multiple Project Expansion Agreements With Existing Customers